Related Experiment Video
Updated: Jul 28, 2026

11:14
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
59.1K
New Adamantyl Chalcones: Synthesis, Antimicrobial and Anticancer Activities
Aouatef Tabbi, Dahmane Tebbani1, Angelamaria Caporale
1Department of chemistry, Faculty of sciences, Mentouri University, 25000 Constantine, Algeria.
Current Topics in Medicinal Chemistry
|August 26, 2016
Summary
New adamantyl chalcones show potent antibacterial and antifungal properties. These compounds also exhibit promising anticancer activity against human pancreas cancer cells in vitro.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Antimicrobial Research
Background:
- Chalcones are a class of natural compounds with diverse biological activities.
- Adamantyl chalcones represent a novel structural class with potential therapeutic applications.
Purpose of the Study:
- To synthesize and characterize a new series of adamantyl chalcones.
- To evaluate the antimicrobial and anticancer activities of these novel compounds.
Main Methods:
- Claisen-Schmidt reaction for synthesis of adamantyl chalcones.
- Spectroscopic data (NMR, Mass Spectrometry) and X-ray crystallography for structural confirmation.
- In vitro antimicrobial assays against Gram-positive and Gram-negative bacteria and pathogenic fungi.
- In vitro antitumor assays against human pancreas cancer cell line (Miapaca2).
Main Results:
- A series of adamantyl chalcones (2, 3a-o) were synthesized in good yields.
- Compounds demonstrated significant antibacterial activity against *Enterococcus faecali*, *Pseudomonas aeruginosa*, and *Escherichia coli*.
- Notable antifungal activity was observed against *Candida glabrata*.
- The synthesized chalcones exhibited anticancer activity against Miapaca2 cells.
Conclusions:
- Adamantyl chalcones are a promising scaffold for developing new antimicrobial agents.
- These compounds warrant further investigation for their potential as anticancer therapeutics, particularly for pancreatic cancer.

